Webinar Details & Objectives

Dr. Colleen Leners, AACN Director of Policy, will be presenting on AACN’s mini-grants that are disseminated through the National Institute on Drug Abuse (NIDA). Since 2017, AACN and the National Institute of Drug Abuse have partnered to advance research, dissemination, and adoption of evidence-based projects (EBP) focusing on Substance Use Disorders (SUDs) treatment practices in health care. The NIDA Blending Initiative: Moving Science from Research to Practice offers an award up to $10,000 for a graduate student (Master’s, Doctoral, or Post-Doctoral) from an accredited program at an AACN member school. This funding is intended to support projects that contribute to a student’s knowledge of SUDs and advance research, dissemination, and adoption of evidence-based SUD treatment. Students are encouraged to develop projects that address or improve current gaps in dissemination of research findings or implementation/adoption of evidence-based treatment practices. The project results will be presented via poster at an AACN conference.

Objectives:

  • Spread education about the grant opportunity with NIDA
  • Explain how to apply for the grant successfully
  • Drive dissemination of crucial substance-abuse research

Pricing and CE Credit

This webinar is free to deans, faculty, staff and students from AACN member schools of nursing. All non-member audiences will be required to pay a $59 webinar fee.

Continuing Education Credits

Eligible attendees may receive one continuing nursing education (CNE) contact hour for participating in this webinar. The American Association of Colleges of Nursing (AACN) is an accredited CNE-provider by the American Nurses Credentialing Center’s Commission on Accreditation. The Association of Schools and Programs of Public Health (ASPPH) works with the National Board of Public Health Examiners (NBPHE) to provide CPH credits.

Site Maintenance

Our system is currently down for scheduled maintenance. Your member services will be available again shortly. Please check back soon.